Outcome of patients with septic shock and high-dose vasopressor therapy

作者
Thomas Auchet,Marie-Alix Régnier,Nicolas Girerd,Bruno Lévy
出处
期刊:Annals of Intensive Care [Springer Nature]
卷期号:7 (1): 43-43 被引量:168
标识
DOI:10.1186/s13613-017-0261-x
摘要

BACKGROUND: Despite the dissemination of international guidelines, mortality from septic shock remains high. Norepinephrine is recommended as first-line vasopressor therapy with a target mean arterial pressure of 65 mmHg. High-dose vasopressor (HDV) may also be required. This study aimed to assess survival in patients with septic shock requiring HDV. We conducted a retrospective study of patients admitted between January 2008 and December 2013 to a 13-bed ICU for septic shock and receiving high-dose vasopressor therapy (defined by a dose >1 µg/kg/min). Primary outcome was 28-day mortality (D28). Secondary outcomes were 90-day mortality (D90), organ failure score (SOFA), duration of organ failure, duration and dosage of vasopressor agent and ischemic complications. RESULTS: In our cohort of 106 patients, mortality reached 60.4% at D28 and 66.3% at D90. One in two patients died before D10. The weight-based mean dose of vasopressor (WMD) represented the best prognostic factor. Using a cutoff of 0.75 µg/kg/min, WMD was associated with mortality with a sensitivity of 73% and specificity of 74%. The mortality rate reached 86.4% when WMD was above the cutoff value and associated with a SOFA score >10. Digital or limb necrosis was documented in 6 patients (5.7%). CONCLUSIONS: In total, 40% of septic shock patients receiving high-dose vasopressor therapy survived at day 28 after admission. A WMD cutoff value of 0.75 µg/kg/min, associated with a >10 SOFA score, was a strong predictor of death. These results provide insights into outcome of refractory septic shock, showing that administration of high-dose vasopressor may indeed be useful in these patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一篮子青柠檬完成签到,获得积分10
刚刚
sss完成签到 ,获得积分10
刚刚
lllllll完成签到,获得积分10
刚刚
雾随风完成签到,获得积分10
刚刚
机智的著完成签到,获得积分10
刚刚
张华完成签到,获得积分10
刚刚
派大星完成签到,获得积分10
刚刚
小鱼完成签到,获得积分10
1秒前
ren完成签到,获得积分10
1秒前
852的应助被ZC采纳,获得10
1秒前
lele完成签到,获得积分10
1秒前
force完成签到,获得积分10
1秒前
wz完成签到,获得积分10
1秒前
时衍完成签到,获得积分10
1秒前
个性笑白完成签到,获得积分10
2秒前
有魅力以珊完成签到,获得积分10
2秒前
yuta123完成签到,获得积分10
2秒前
kevin231的应助被hw采纳,获得10
2秒前
Wakeupsn完成签到,获得积分10
2秒前
世洁完成签到 ,获得积分10
2秒前
隐形又柔发布了新的文献求助10
2秒前
西洲长风完成签到,获得积分10
3秒前
ChemNiko完成签到,获得积分10
3秒前
张大诚完成签到,获得积分10
4秒前
无私的亦巧完成签到,获得积分10
4秒前
虾仁不wink完成签到,获得积分10
4秒前
2361760724完成签到,获得积分10
4秒前
4秒前
大蛋完成签到,获得积分10
4秒前
aaa4完成签到,获得积分10
4秒前
富贵完成签到,获得积分10
4秒前
null的应助被树人采纳,获得10
4秒前
Yang完成签到,获得积分10
5秒前
5秒前
颜凡桃完成签到,获得积分10
5秒前
自信的寄松完成签到 ,获得积分10
6秒前
科研通AI6.4的应助被wx采纳,获得10
6秒前
自信的竹员外完成签到,获得积分10
6秒前
Qinghua完成签到,获得积分10
6秒前
活力的夏旋完成签到,获得积分20
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152226
求助须知:如何正确求助?哪些是违规求助? 9549007
关于积分的说明 21689901
捐赠科研通 7740494
什么是DOI,文献DOI怎么找? 3425145
关于科研通互助平台的介绍 2550358
邀请新用户注册赠送积分活动 2468652